Factual end-of-day data for JUBLPHARMA: price and volume, delivery percentage, 52-week position, indicator levels and intraday order flow. Refreshed after every NSE session.
Traded volume of 1,08,892 shares was well below the 20-day average (0.3×).
JUBLPHARMA's delivery share of 60.2% was above its 20-day average of 53.2%.
Intraday order-flow data from VolumeLens tick classification — the running difference between aggressive buying and selling volume. This dataset is not published by any other Indian platform.
Large-trade volume split: 2,310 shares on the buy side vs 1,810 on the sell side.
Largest single buy-side trade: 1,810 shares at ₹895.00.
| Indicator | Reading (26 Aug 2026) |
|---|---|
| RSI (14) | 40.1 |
| 50-day EMA | ₹935.47 — close is below |
| 200-day EMA | ₹983.40 — close is below |
| SuperTrend (10, 3) | ₹981.39 — close is below the line |
Indicator values are computed from adjusted daily closes and describe where price sits relative to each level — they are statistics, not signals.
JUBLPHARMA is a mid-cap NSE stock in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry), with a market capitalisation of about ₹17,189 crore.
Footprint chart, DOM ladder, cumulative delta and volume profile — free to explore.
On 26 Aug 2026, 60.2% of JUBLPHARMA's traded volume was marked for delivery (65,507 shares delivered). The 20-day average delivery is 53.2%.
JUBLPHARMA closed at ₹887.40 on 26 Aug 2026 (-1.03% vs the previous close).
52-week high ₹1,183.00, 52-week low ₹786.05. The latest close is -24.99% from the 52-week high.